Literature DB >> 4541684

Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa.

R H Henderson, H Davis, D L Eddins, W H Foege.   

Abstract

In 1966, nineteen countries of West and Central Africa began a regional smallpox eradication and measles control programme in cooperation with the World Health Organization. This paper summarizes sample survey data collected to assess the results of the programme in Northern Nigeria (Sokoto and Katsina Provinces), Western Nigeria, Niger, Dahomey, and Togo. These data indicate that the programme, which used mass vaccination campaigns based on a collecting-point strategy, was generally successful in reaching a high proportion of the population. Analysis of vaccination coverage and vaccination scar rates by age underlined the importance to the programme of newborn children who accumulate rapidly following the mass campaign. Of all persons without vaccination scars at the time of the surveys, 34.4% were under 5 years of age; in the absence of a maintenance programme, this figure would rise to 40% after 1 year.

Entities:  

Mesh:

Year:  1973        PMID: 4541684      PMCID: PMC2481004     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil.

Authors:  J D Millar; L Morris; A Macedo Filho; T M Mack; W Dyal; A A Medeiros
Journal:  Trop Geogr Med       Date:  1971-03
  1 in total
  21 in total

1.  Smallpox eradication in West and Central Africa.

Authors:  W H Foege; J D Millar; D A Henderson
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Varicella vaccine uptake in Shandong Province, China.

Authors:  Aiqiang Xu; Qing Xu; Xueqiang Fang; Stephanie Bialek; Chengbin Wang
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Sociological perspectives on biologicals research in human populations.

Authors:  D Crane
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program.

Authors:  Ursula Panzner; Gi Deok Pak; Peter Aaby; Yaw Adu-Sarkodie; Mohammad Ali; Abraham Aseffa; Stephen Baker; Morten Bjerregaard-Andersen; John A Crump; Jessica Deerin; Ligia Maria Cruz Espinoza; Nagla Gasmelseed; Jean Noël Heriniaina; Julian T Hertz; Justin Im; Vera von Kalckreuth; Karen H Keddy; Bruno Lankoande; Sandra Løfberg; Christian G Meyer; Michael Munishi Oresto; Jin Kyung Park; Se Eun Park; Raphaël Rakotozandrindrainy; Nimako Sarpong; Abdramane Bassiahi Soura; Amy Gassama Sow; Adama Tall; Mekonnen Teferi; Alemayehu Worku; Biruk Yeshitela; Thomas F Wierzba; Florian Marks
Journal:  Clin Infect Dis       Date:  2016-03-15       Impact factor: 9.079

5.  Impact of population density on immunization programmes.

Authors:  I Arita; J Wickett; F Fenner
Journal:  J Hyg (Lond)       Date:  1986-06

6.  A programme of multiple-antigen childhood immunization in Yaoundé, Cameroon: first-year evaluation, 1975-1976.

Authors:  B Guyer; S Atangana
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

7.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.

Authors:  R H Henderson; T Sundaresan
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

8.  Monitoring selective components of primary health care: methodology and community assessment of vaccination, diarrhoea, and malaria practices in Conakry, Guinea. ACSI-CCCD team.

Authors:  F Dabis; J G Breman; A J Roisin; F Haba
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

9.  Intent to receive pandemic influenza A (H1N1) vaccine, compliance with social distancing and sources of information in NC, 2009.

Authors:  Jennifer A Horney; Zack Moore; Meredith Davis; Pia D M MacDonald
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

10.  Ethical dilemmas in malaria drug and vaccine trials: a bioethical perspective.

Authors:  M Barry; M Molyneux
Journal:  J Med Ethics       Date:  1992-12       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.